Commerzbank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-270,600	Closed	-$2.05M	–	864
2019 Q2	$2.05M	Buy	+270,600	New	+$12.6M	0.02%	465
2019 Q1	–	Sell	-159,000	Closed	-$433K	–	881
2018 Q4	$433K	Buy	159,000 +100,000	+169%	+$5.37M	﹤0.01%	690
2018 Q3	$67K	Sell	59,000 -111,000	-65%	-$6.59M	﹤0.01%	937
2018 Q2	$390K	Buy	+170,000	New	+$9.18M	﹤0.01%	716
2016 Q1	–	Sell	-50,000	Closed	-$3.44M	–	1047
2015 Q4	$3.44M	Hold	50,000	–	–	0.03%	375
2015 Q3	$2.96M	Hold	50,000	–	–	0.02%	376
2015 Q2	$3.33M	Hold	50,000	–	–	0.02%	458
2015 Q1	$3.23M	Sell	50,000 -50,000	-50%	-$3.13M	0.02%	484
2014 Q4	$5.9M	Buy	100,000 +50,000	+100%	+$2.82M	0.04%	372
2014 Q3	$2.56M	Sell	50,000 -150,000	-75%	-$7.49M	0.01%	678
2014 Q2	$9.7M	Buy	200,000 +160,000	+400%	+$7.88M	0.05%	275
2014 Q1	$2.08M	Sell	40,000 -64,200	-62%	-$3.42M	0.01%	702
2013 Q4	$5.21M	Buy	104,200 +200	+0.2%	+$10.2K	0.03%	450
2013 Q3	$4.81M	Sell	104,000 -1,000	-1%	-$43.9K	0.02%	476
2013 Q2	$4.69M	Buy	+105,000	New	+$4.56M	0.02%	555

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commerzbank Aktiengesellschaft's BMY Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, selling an estimated $42.2K and leaving 13,733 shares worth $833K. The position accounts for 0.02% of the portfolio, ranked #221.

Commerzbank Aktiengesellschaft first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q4 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Commerzbank Aktiengesellschaft held 13,733 shares of Bristol-Myers Squibb worth $833K as of Q1 2026.
Commerzbank Aktiengesellschaft sold 724 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.2K.
Bristol-Myers Squibb made up 0.02% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #221 holding.
Commerzbank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
Commerzbank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $48.6M in Q4 2019.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.